Pre-earnings options volume in Viking Therapeutics is 4.6x normal with calls leading puts 19:5. Implied volatility suggests the market is anticipating a move near 11.2%, or $1.06, after results are released. Median move over the past eight quarters is 3.2%.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VKTX:
- Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
- Cantor Fitzgerald biotech analyst to hold analyst/industry conference call
- Aligos Therapeutics price target raised to $7 from $3 at Piper Sandler
- Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809
- Viking Therapeutics call volume above normal and directionally bullish
